Molecular mechanisms of miR-1236 in the assessment of tumor lymphangiogenesis in human ovarian cancer patients.

Khademi, Mahsa; Babaei, Zeinab; Ghorbanhosseini, Seyedeh Sara; Emami Razavi, Amirnader; Aghaei, Mahmoud

Khademi, Mahsa; Babaei, Zeinab; Ghorbanhosseini, Seyedeh Sara; Emami Razavi, Amirnader; Aghaei, Mahmoud.

Khademi M; Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Babaei Z; Department of Clinical Biochemistry and Biophysics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Ghorbanhosseini SS; Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Emami Razavi A; Iran National Tumor Bank, Cancer Biology Research Center, Cancer Institute of Iran. Tehran University of Medical Sciences, Tehran, Iran.
Aghaei M; Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

J Gene Med ; 25(5): e3480, 2023 05.

Article en En | MEDLINE | ID: mdl-36750632

Asunto(s)

MicroARNs; Neoplasias Ováricas; Humanos; Femenino; Linfangiogénesis/fisiología; Factor C de Crecimiento Endotelial Vascular/análisis; Factor C de Crecimiento Endotelial Vascular/genética; Factor C de Crecimiento Endotelial Vascular/metabolismo; Factor A de Crecimiento Endotelial Vascular; Biomarcadores

Palabras clave

VEGF-C; VEGFR3; lymphangiogenesis; miR-1236; ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / MicroARNs Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google